130.31
-2.19(-1.65%)
Currency In USD
Previous Close | 132.5 |
Open | 131.85 |
Day High | 132.81 |
Day Low | 130.16 |
52-Week High | 249.91 |
52-Week Low | 108.9 |
Volume | 712,975 |
Average Volume | 583,895 |
Market Cap | 5.76B |
PE | 30.38 |
EPS | 4.29 |
Moving Average 50 Days | 120.79 |
Moving Average 200 Days | 143 |
Change | -2.19 |
If you invested $1000 in Teleflex Incorporated (TFX) 10 years ago, it would be worth $997.7 as of September 15, 2025 at a share price of $130.31. Whereas If you bought $1000 worth of Teleflex Incorporated (TFX) shares 5 years ago, it would be worth $360.24 as of September 15, 2025 at a share price of $130.31.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients
GlobeNewswire Inc.
Sep 11, 2025 10:30 AM GMT
The Trial Evaluates a Combined PCI Approach Using Drug-Coated Balloons and Drug-Eluting StentsWAYNE, Pa., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the en
Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
GlobeNewswire Inc.
Aug 26, 2025 10:30 AM GMT
WAYNE, Pa., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Management of Teleflex Incorporated (NYSE: TFX) will be presenting at the Morgan Stanley 23rd Annual Global Healthcare Conference at the Sheraton New York Times Square, on Tuesday, September 9, 2025, at
Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a Proven Safe and Effective Option to Minimize the Harmful Long-Term Side Effects of Prostate Radiation Therapy
GlobeNewswire Inc.
Aug 19, 2025 10:30 AM GMT
Innovative hyaluronic acid technology delivers enhanced control and precision, significantly lowering the risk of rectal toxicity during prostate radiation treatment.1-4Initial cases have now been performed in Japan. WAYNE, Pa., Aug. 19, 2025 (GLOB